HY-10209A |
Masitinib (mesylate) |
Masitinib(AB-1010)甲磺酸盐是新型的Kit,PDGFRα和β抑制剂,IC50分别为200 nM,540 nM和800 nM,对ABL和c-Fms抑制性较弱。 |
1048007-93-7 |
AB1010 mesylate; Masivet mesylate; AB-1010 mesylate; AB 1010 mesylate |
HY-10260B |
Vandetanib (hydrochloride) |
Vandetanib (ZD6474)盐酸盐是VEGFR2抑制剂,IC50为40 nM。 |
524722-52-9 |
Zactima hydrochloride; ZD6474 hydrochloride;ZD-6474 hydrochloride; ZD 6474 hydrochloride |
HY-10260A |
Vandetanib (trifluoroacetate) |
Vandetanib (ZD6474)三氟醋酸盐是VEGFR2抑制剂,IC50为40 nM。 |
338992-53-3 |
Zactima trifluoroacetate; ZD6474 trifluoroacetate;ZD-6474 trifluoroacetate; ZD 6474 trifluoroacetate |
HY-A0003A |
Lenalidomide (hydrochloride) |
Lenalidomide(Revlimid, CC-5013)盐酸盐是TNF-α抑制剂,IC50为13 nM。 |
1243329-97-6 |
Revlimid hydrochloride;CC-5013 hydrochloride;CC5013 hydrochloride;CC 5013 hydrochloride |
HY-50895A |
Gefitinib (hydrochloride)吉非替尼(盐酸盐) |
Gefitinib(ZD-1839)盐酸盐是EGFR抑制,对肿瘤中的EGFR突变和过度活化有效。 |
184475-55-6 |
Iressa hydrochloride;ZD 1839 hydrochloride;ZD-1839 hydrochloride;ZD1839 hydrochloride |
HY-12008A |
Erlotinib (mesylate) |
Erlotinib(NSC 718781; OSI-774; CP-358774)甲磺酸盐是人EGFR抑制剂,IC50为2 nM |
248594-19-6 |
Tarceva;CP-358774;OSI-774;NSC 718781;R 1415 |
HY-10181A |
Dasatinib (hydrochloride)达沙替尼(盐酸盐) |
Dasatinib(BMS-354825)盐酸盐是Abl/ Src的双重抑制剂,IC50分别为<1 nM和0.8 nM,还抑制c-Kit(野生型)、c-Kit (D816V),IC50分别为79 nM和37 nM。 |
854001-07-3 |
BMS-354825 hydrochloride;Sprycel hydrochloride;BMS354825 hydrochloride;BMS 354825 hydrochloride |
HY-13521A |
SB-505124 (hydrochloride) |
SB505124盐酸盐是TGFβ受体ALK4和ALK5抑制剂,IC50分别为129 nM和47 nM,还能抑制ALK7,但对ALK1,2,3和6无抑制性。 |
356559-13-2 |
SB 505124 hydrochloride;SB505124 hydrochloride |
HY-A0059 |
Nifuratel硝呋太尔 |
Nifuratel(NF 113, SAP 113)是广谱抗生素,具有抗细菌、真菌和毛滴虫的活性。 |
4936-47-4 |
NF 113;SAP 113;Methylmercadone |
HY-13918 |
Etimizol |
Etimizol(Ethymisole; Antiffine; Ethylnorantifein)可有效地作用于缺氧造成的失忆症。 |
64-99-3 |
Ethymisole;Antiffine;Ethimizole;Ethylnorantifein;Ethylnorantifeine;Ethylnorantiffeine;Ethymisol;Ethymisole;Etimizole |